Evidence map›Paper›PMID 27152414›Full record

ArticlePloS one2016

Why p-OMe- and p-Cl-β-Methylphenethylamines Display Distinct Activities upon MAO-B Binding.

Angélica Fierro, Dale E Edmondson, Cristian Celis-Barros, Marco Rebolledo-Fuentes, Gerald Zapata-Torres

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Prominent Neuroprotective Potential of Indole-2-Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  2. Why Monoamine Oxidase B Preferably MetabolizesInternational journal of molecular sciences · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Angélica FierroFacultad de Química, Departamento de Química Orgánica, Pontificia Universidad Católica de Chile, Santiago, Chile.
Dale E EdmondsonDepartments of Chemistry and Biochemistry, Emory University, Atlanta, GA, United States of America.
Cristian Celis-BarrosUniversidad Andres Bello, Facultad de Ciencias Exactas, Departamento de Ciencias Quimicas, Santiago, Chile.
Marco Rebolledo-FuentesDepartment of Chemistry, Faculty of Sciences, University of Chile, Santiago, Chile.
Gerald Zapata-TorresFaculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.
University of Chile · CLEmory University · USPontificia Universidad Católica de Chile · CLUniversidad Andrés Bello · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite their structural and chemical commonalities, p-chloro-β-methylphenethylamine and p-methoxy-β-methylphenethylamine display distinct inhibitory and substrate activities upon MAO-B binding. Density Functional Theory (DFT) quantum chemical calculations reveal that β-methylation and para-substitution underpin the observed activities sustained by calculated transition state energy barriers, attained conformations and key differences in their interactions in the enzyme's substrate binding site. Although both compounds meet substrate requirements, it is clear that β-methylation along with the physicochemical features of the para-substituents on the aromatic ring determine the activity of these compounds upon binding to the MAO B-isoform. While data for a larger set of compounds might lend generality to our conclusions, our experimental and theoretical results strongly suggest that the contrasting activities displayed depend on the conformations adopted by these compounds when they bind to the enzyme.

Indexed as

AmphetaminesCarbon-13 Magnetic Resonance SpectroscopyModels, MolecularMonoamine OxidaseProton Magnetic Resonance SpectroscopySubstrate SpecificityThermodynamicsAmphetaminesbeta-methylphenyl-ethylamineMonoamine Oxidase

Identifiers

PMID27152414
PMCPMC4859490
OpenAlexW2345648758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.